Emerging roles for vascular smooth muscle cell exosomes in calcification and coagulation

Journal of Physiology

Volumn 594, Issue 11, 2016, Pages 2905-2914

  Kapustin, A N ^a   Shanahan, C M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANNEXIN; CALCIUM PHOSPHATE; CALPHOBINDIN II; GELATINASE A; MICRORNA; PHOSPHATIDYLSERINE; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN PHOSPHODIESTERASE 3; UNCLASSIFIED DRUG; MMP2 PROTEIN, HUMAN; SMPD3 PROTEIN, HUMAN;

ACTIN FILAMENT; APOPTOSIS; BLOOD CLOTTING; BONE DEVELOPMENT; CALCIFICATION; CALCIUM HOMEOSTASIS; CARTILAGE CELL; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR SECRETION; CYTOSOL; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; ENZYME ACTIVITY; EXOSOME; HUMAN; MATRIX VESICLE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; BLOOD VESSEL CALCIFICATION; METABOLISM; PATHOLOGY; VASCULAR SMOOTH MUSCLE;

ANIMALS; EXOSOMES; HUMANS; MATRIX METALLOPROTEINASE 2; MUSCLE, SMOOTH, VASCULAR; SPHINGOMYELIN PHOSPHODIESTERASE; VASCULAR CALCIFICATION;

EID: 84960401106     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP271340     Document Type: Review

References (92)

1. Anderson HC (1995). Molecular biology of matrix vesicles. Clin Orthop Relat Res, 266-280.
2. Aubin I, Adams CP, Opsahl S, Septier D, Bishop CE, Auge N, Salvayre R, Negre-Salvayre A, Goldberg M, Guenet JL & Poirier C (2005). A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse. Nat Genet 37, 803-805.
3. Auge N, Nikolova-Karakashian M, Carpentier S, Parthasarathy S, Negre-Salvayre A, Salvayre R, Merrill AH Jr & Levade T (1999). Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase. J Biol Chem 274, 21533-21538.
4. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, Ivarsson Y, Depoortere F, Coomans C, Vermeiren E, Zimmermann P & David G (2012). Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 14, 677-685.
5. Bobryshev YV, Killingsworth MC, Huynh TG, Lord RS, Grabs AJ & Valenzuela SM (2007). Are calcifying matrix vesicles in atherosclerotic lesions of cellular origin? Basic Res Cardiol 102, 133-143.
6. Bombeli T, Karsan A, Tait JF & Harlan JM (1997). Apoptotic vascular endothelial cells become procoagulant. Blood 89, 2429-2442.
7. Buckwalter JA, Mower D & Schaeffer J (1987). Differences in matrix vesicle concentration among growth plate zones. J Orthop Res 5, 157-163.
8. Buschow SI, Liefhebber JM, Wubbolts R & Stoorvogel W (2005). Exosomes contain ubiquitinated proteins. Blood Cells Mol Dis 35, 398-403.
9. Chae YM, Heo SH, Kim JY, Lee JM, Ryoo HM & Cho JY (2009). Upregulation of smpd3 via BMP2 stimulation and Runx2. BMB Rep 42, 86-90.
10. Chamley-Campbell J, Campbell GR & Ross R (1979). The smooth muscle cell in culture. Physiol Rev 59, 1-61.
11. Chen NX, O'Neill KD, Chen X & Moe SM (2008). Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res 23, 1798-1805.
12. Cinq-Frais C, Coatrieux C, Savary A, D'Angelo R, Bernis C, Salvayre R, Negre-Salvayre A & Auge N (2015). Annexin II-dependent actin remodelling evoked by hydrogen peroxide requires the metalloproteinase/sphingolipid pathway. Redox Biol 4, 169-179.
13. Colombo M, Moita C, van Niel G, Kowal J, Vigneron J, Benaroch P, Manel N, Moita LF, Thery C & Raposo G (2013). Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci 126, 5553-5565.
14. Crawley J, Lupu F, Westmuckett AD, Severs NJ, Kakkar VV & Lupu C (2000). Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol 20, 1362-1373.
15. Deaton RA, Gan Q & Owens GK (2009). Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. Am J Physiol Heart Circ Physiol 296, H1027-H1037.
16. Del Conde I, Shrimpton CN, Thiagarajan P & Lopez JA (2005). Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106, 1604-1611.
17. Deng L, Blanco FJ, Stevens H, Lu R, Caudrillier A, McBride MW, McClure JD, Grant JS, Thomas M, Frid MG, Stenmark KR, White K, Seto AG, Morrell NW, Bradshaw AC, MacLean MR & Baker AH (2015). miR-143 activation regulates smooth muscle and endothelial cell crosstalk in pulmonary arterial hypertension. Circ Res 117, 870-883.
18. Egorina EM, Sovershaev MA, Bjorkoy G, Gruber FX, Olsen JO, Parhami-Seren B, Mann KG & Osterud B (2005). Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability. Arterioscler Thromb Vasc Biol 25, 1493-1498.
19. Ettelaie C, Collier ME, Maraveyas A & Ettelaie R (2014). Characterization of physical properties of tissue factor-containing microvesicles and a comparison of ultracentrifuge-based recovery procedures. J Extracell Vesicles 3, doi: 10.3402/jev.v3.23592.
20. Ewence AE, Bootman M, Roderick HL, Skepper JN, McCarthy G, Epple M, Neumann M, Shanahan CM & Proudfoot D (2008). Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization. Circ Res 103, e28-e34.
21. Fang Y, Wu N, Gan X, Yan W, Morrell JC & Gould SJ (2007). Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes. PLoS Biol 5, e158.
22. Flynn PD, Byrne CD, Baglin TP, Weissberg PL & Bennett MR (1997). Thrombin generation by apoptotic vascular smooth muscle cells. Blood 89, 4378-4384.
23. Gardiner C, Harrison P, Belting M, Boing A, Campello E, Carter BS, Collier ME, Coumans F, Ettelaie C, van Es N, Hochberg FH, Mackman N, Rennert RC, Thaler J, Rak J & Nieuwland R (2015). Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day. J Extracell Vesicles 4, 26901.
24. Garnier D, Magnus N, Lee TH, Bentley V, Meehan B, Milsom C, Montermini L, Kislinger T & Rak J (2012). Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor. J Biol Chem 287, 43565-43572.
25. Genge BR, Wu LN & Wuthier RE (1989). Identification of phospholipid-dependent calcium-binding proteins as constituents of matrix vesicles. J Biol Chem 264, 10917-10921.
26. Genge BR, Wu LN & Wuthier RE (2007). In vitro modeling of matrix vesicle nucleation: synergistic stimulation of mineral formation by annexin A5 and phosphatidylserine. J Biol Chem 282, 26035-26045.
27. 2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6, 449-461.
28. Gomez D & Owens GK (2012). Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 95, 156-164.
29. Guo DC, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N, Bourgeois S, Estrera AL, Safi HJ, Sparks E, Amor D, Ades L, McConnell V, Willoughby CE, Abuelo D, Willing M, Lewis RA, Kim DH, Scherer S, Tung PP, Ahn C, Buja LM, Raman CS, Shete SS & Milewicz DM (2007). Mutations in smooth muscle α-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 39, 1488-1493.
30. Harding C, Heuser J & Stahl P (1983). Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol 97, 329-339.
31. Huang J, Wang T, Wright AC, Yang J, Zhou S, Li L, Yang J, Small A & Parmacek MS (2015). Myocardin is required for maintenance of vascular and visceral smooth muscle homeostasis during postnatal development. Proc Natl Acad Sci USA 112, 4447-4452.
32. Hutcheson JD, Goettsch C, Pham T, Iwashita M, Aikawa M, Singh SA & Aikawa E (2014a). Enrichment of calcifying extracellular vesicles using density-based ultracentrifugation protocol. J Extracell Vesicles 3, 25129.
33. Hutcheson JD, Maldonado N & Aikawa E (2014b). Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability. Curr Opin Lipidol 25, 327-332.
34. Iannotti JP & Brighton CT (1989). Cytosolic ionized calcium concentration in isolated chondrocytes from each zone of the growth plate. J Orthop Res 7, 511-518.
35. Kakoi H, Maeda S, Shinohara N, Matsuyama K, Imamura K, Kawamura I, Nagano S, Setoguchi T, Yokouchi M, Ishidou Y & Komiya S (2014). Bone morphogenic protein (BMP) signaling up-regulates neutral sphingomyelinase 2 to suppress chondrocyte maturation via the Akt protein signaling pathway as a negative feedback mechanism. J Biol Chem 289, 8135-8150.
36. Kapustin AN, Chatrou ML, Drozdov I, Zheng Y, Davidson SM, Soong D, Furmanik M, Sanchis P, De Rosales RT, Alvarez-Hernandez D, Shroff R, Yin X, Muller K, Skepper JN, Mayr M, Reutelingsperger CP, Chester A, Bertazzo S, Schurgers LJ & Shanahan CM (2015). Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. Circ Res 116, 1312-1323.
37. Kapustin AN, Davies JD, Reynolds JL, McNair R, Jones GT, Sidibe A, Schurgers LJ, Skepper JN, Proudfoot D, Mayr M & Shanahan CM (2011). Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ Res 109, e1-e12.
38. Khavandgar Z, Poirier C, Clarke CJ, Li J, Wang N, McKee MD, Hannun YA & Murshed M (2011). A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralization. J Cell Biol 194, 277-289.
39. Kirsch T, Nah HD, Shapiro IM & Pacifici M (1997). Regulated production of mineralization-competent matrix vesicles in hypertrophic chondrocytes. J Cell Biol 137, 1149-1160.
40. Krishnaswamy S, Field KA, Edgington TS, Morrissey JH & Mann KG (1992). Role of the membrane surface in the activation of human coagulation factor X. J Biol Chem 267, 26110-26120.
41. Kuang SQ, Kwartler CS, Byanova KL, Pham J, Gong L, Prakash SK, Huang J, Kamm KE, Stull JT, Sweeney HL & Milewicz DM (2012). Rare, nonsynonymous variant in the smooth muscle-specific isoform of myosin heavy chain, MYH11, R247C, alters force generation in the aorta and phenotype of smooth muscle cells. Circ Res 110, 1411-1422.
42. Leroyer AS, Isobe H, Leseche G, Castier Y, Wassef M, Mallat Z, Binder BR, Tedgui A & Boulanger CM (2007). Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 49, 772-777.
43. Li J, Zhang Y, Liu Y, Dai X, Li W, Cai X, Yin Y, Wang Q, Xue Y, Wang C, Li D, Hou D, Jiang X, Zhang J, Zen K, Chen X & Zhang CY (2013). Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis. J Biol Chem 288, 23586-23596.
44. Llorente-Cortes V, Otero-Vinas M, Camino-Lopez S, Llampayas O & Badimon L (2004). Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells. Circulation 110, 452-459.
45. Loyer X, Vion AC, Tedgui A & Boulanger CM (2014). Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res 114, 345-353.
46. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM & Tedgui A (1999). Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99, 348-353.
47. Mandal SK, Pendurthi UR & Rao LV (2006). Cellular localization and trafficking of tissue factor. Blood 107, 4746-4753.
48. Mann KG (2011). Thrombin generation in hemorrhage control and vascular occlusion. Circulation 124, 225-235.
49. McNamara CA, Sarembock IJ, Gimple LW, Fenton JW 2nd, Coughlin SR & Owens GK (1993). Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 91, 94-98.
50. Mellgren RL, Zhang W, Miyake K & McNeil PL (2007). Calpain is required for the rapid, calcium-dependent repair of wounded plasma membrane. J Biol Chem 282, 2567-2575.
51. Mulder AB, Smit JW, Bom VJ, Blom NR, Ruiters MH, Halie MR & van der Meer J (1996). Association of smooth muscle cell tissue factor with caveolae. Blood 88, 1306-1313.
52. Nadra I, Mason JC, Philippidis P, Florey O, Smythe CD, McCarthy GM, Landis RC & Haskard DO (2005). Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? Circ Res 96, 1248-1256.
53. Nemenoff RA, Horita H, Ostriker AC, Furgeson SB, Simpson PA, VanPutten V, Crossno J, Offermanns S & Weiser-Evans MC (2011). SDF-1alpha induction in mature smooth muscle cells by inactivation of PTEN is a critical mediator of exacerbated injury-induced neointima formation. Arterioscler Thromb Vasc Biol 31, 1300-1308.
54. Nemerson Y (1988). Tissue factor and hemostasis. Blood 71, 1-8.
55. New SE, Goettsch C, Aikawa M, Marchini JF, Shibasaki M, Yabusaki K, Libby P, Shanahan CM, Croce K & Aikawa E (2013). Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques. Circ Res 113, 72-77.
56. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP, Goud B, Benaroch P, Hacohen N, Fukuda M, Desnos C, Seabra MC, Darchen F, Amigorena S, Moita LF & Thery C (2010). Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 12, 19-30.
57. Patterson C, Stouffer GA, Madamanchi N & Runge MS (2001). New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology. Circ Res 88, 987-997.
58. Pidkovka NA, Cherepanova OA, Yoshida T, Alexander MR, Deaton RA, Thomas JA, Leitinger N & Owens GK (2007). Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ Res 101, 792-801.
59. Raposo G & Stoorvogel W (2013). Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200, 373-383.
60. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL & Shanahan CM (2004). Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15, 2857-2867.
61. Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, Weissberg PL, Jahnen-Dechent W & Shanahan CM (2005). Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 16, 2920-2930.
62. Robbins CS, Hilgendorf I, Weber GF, Theurl I, Iwamoto Y, Figueiredo JL, Gorbatov R, Sukhova GK, Gerhardt LM, Smyth D, Zavitz CC, Shikatani EA, Parsons M, van Rooijen N, Lin HY, Husain M, Libby P, Nahrendorf M, Weissleder R & Swirski FK (2013). Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 19, 1166-1172.
63. Rojas E, Pollard HB, Haigler HT, Parra C & Burns AL (1990). Calcium-activated endonexin II forms calcium channels across acidic phospholipid bilayer membranes. J Biol Chem 265, 21207-21215.
64. Rong JX, Shapiro M, Trogan E & Fisher EA (2003). Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci USA 100, 13531-13536.
65. Sage AP, Lu J, Tintut Y & Demer LL (2011). Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 79, 414-422.
66. Savina A, Fader CM, Damiani MT & Colombo MI (2005). Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic 6, 131-143.
67. Schecter AD, Giesen PL, Taby O, Rosenfield CL, Rossikhina M, Fyfe BS, Kohtz DS, Fallon JT, Nemerson Y & Taubman MB (1997). Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J Clin Invest 100, 2276-2285.
68. Schecter AD, Spirn B, Rossikhina M, Giesen PL, Bogdanov V, Fallon JT, Fisher EA, Schnapp LM, Nemerson Y & Taubman MB (2000). Release of active tissue factor by human arterial smooth muscle cells. Circ Res 87, 126-132.
69. Seabra MC & Coudrier E (2004). Rab GTPases and myosin motors in organelle motility. Traffic 5, 393-399.
70. Seasholtz TM, Majumdar M, Kaplan DD & Brown JH (1999). Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration. Circ Res 84, 1186-1193.
71. Sevigny LM, Austin KM, Zhang P, Kasuda S, Koukos G, Sharifi S, Covic L & Kuliopulos A (2011). Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia. Arterioscler Thromb Vasc Biol 31, e100-106.
72. Shanahan CM, Cary NR, Metcalfe JC & Weissberg PL (1994). High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93, 2393-2402.
73. Shanahan CM, Crouthamel MH, Kapustin A & Giachelli CM (2011). Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 109, 697-711.
74. Shankman LS, Gomez D, Cherepanova OA, Salmon M, Alencar GF, Haskins RM, Swiatlowska P, Newman AA, Greene ES, Straub AC, Isakson B, Randolph GJ & Owens GK (2015). KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med 21, 628-637.
75. Shroff RC, Shah V, Hiorns MP, Schoppet M, Hofbauer LC, Hawa G, Schurgers LJ, Singhal A, Merryweather I, Brogan P, Shanahan C, Deanfield J & Rees L (2008). The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 23, 3263-3271.
76. Sims PJ, Faioni EM, Wiedmer T & Shattil SJ (1988). Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263, 18205-18212.
77. Tanimura A, McGregor DH & Anderson HC (1983). Matrix vesicles in atherosclerotic calcification. Proc Soc Exp Biol Med 172, 173-177.
78. Tellier E, Negre-Salvayre A, Bocquet B, Itohara S, Hannun YA, Salvayre R & Auge N (2007). Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway. Mol Cell Biol 27, 2997-3007.
79. Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM & Osanto S (2007). Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5, 520-527.
80. Thomas JA, Deaton RA, Hastings NE, Shang Y, Moehle CW, Eriksson U, Topouzis S, Wamhoff BR, Blackman BR & Owens GK (2009). PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns. Am J Physiol Heart Circ Physiol 296, H442-H452.
81. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernandez-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V & Badimon JJ (1997). Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 95, 594-599.
82. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brugger B & Simons M (2008). Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244-1247.
83. van Balkom BW, de Jong OG, Smits M, Brummelman J, den Ouden K, de Bree PM, van Eijndhoven MA, Pegtel DM, Stoorvogel W, Wurdinger T & Verhaar MC (2013). Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells. Blood 121, 3997-4006, S3991-S3915.
84. Vengrenyuk Y, Nishi H, Long X, Ouimet M, Savji N, Martinez FO, Cassella CP, Moore KJ, Ramsey SA, Miano JM & Fisher EA (2015). Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype. Arterioscler Thromb Vasc Biol 35, 535-546.
85. Vrijsen KR, Sluijter JP, Schuchardt MW, van Balkom BW, Noort WA, Chamuleau SA & Doevendans PA (2010). Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. J Cell Mol Med 14, 1064-1070.
86. Walker RK & Krishnaswamy S (1994). The activation of prothrombin by the prothrombinase complex. The contribution of the substrate-membrane interaction to catalysis. J Biol Chem 269, 27441-27450.
87. Wang W & Kirsch T (2002). Retinoic acid stimulates annexin-mediated growth plate chondrocyte mineralization. J Cell Biol 157, 1061-1069.
88. Wang Z, Wang DZ, Pipes GC & Olson EN (2003). Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci USA 100, 7129-7134.
89. Wilcox JN, Smith KM, Schwartz SM & Gordon D (1989). Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 86, 2839-2843.
90. Wilson CM, Naves T, Vincent F, Melloni B, Bonnaud F, Lalloue F & Jauberteau MO (2014). Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors. J Cell Sci 127, 3983-3997.
91. Wolf P (1967). The nature and significance of platelet products in human plasma. Br J Haematol 13, 269-288.
92. Wu LN, Yoshimori T, Genge BR, Sauer GR, Kirsch T, Ishikawa Y & Wuthier RE (1993). Characterization of the nucleational core complex responsible for mineral induction by growth plate cartilage matrix vesicles. J Biol Chem 268, 25084-25094.